212 related articles for article (PubMed ID: 23402444)
1. Moving the boundaries of international collaboration on clinical trials and QoL: experiences in oncology and legislation within the European Parliament.
Bottomley A; Kirby T; Bean J; Walker J
Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):43-5. PubMed ID: 23402444
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in cancer clinical trials: researchers, patients and policy makers.
Dormer L
Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):661-5. PubMed ID: 22098280
[TBL] [Abstract][Full Text] [Related]
3. Regulating clinical trials in Europe.
Willmott G
Lancet Oncol; 2013 May; 14(6):453-4. PubMed ID: 23522922
[No Abstract] [Full Text] [Related]
4. European Organisation for Research and Treatment of Cancer's point of view.
Meunier F; Lacombe D
Lancet; 2003 Aug; 362(9384):663. PubMed ID: 12944069
[No Abstract] [Full Text] [Related]
5. The need for proportionate regulation of clinical trials.
Kearns P
Lancet Oncol; 2013 May; 14(6):454-5. PubMed ID: 23522923
[No Abstract] [Full Text] [Related]
6. Summary report of the ECHTA/ECAHI project. European Collaboration for Health Technology Assessment/Assessment of Health Interventions.
Jonsson E; Banta HD; Henshall C; Sampietro-Colom L
Int J Technol Assess Health Care; 2002; 18(2):218-37. PubMed ID: 12053423
[No Abstract] [Full Text] [Related]
7. Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA.
Vella Bonanno P; Bucsics A; Simoens S; Martin AP; Oortwijn W; Gulbinovič J; Rothe C; Timoney A; Ferrario A; Gad M; Salem A; Hoxha I; Sauermann R; Kamusheva M; Dimitrova M; Petrova G; Laius O; Selke G; Kourafalos V; Yfantopoulos J; Magnusson E; Joppi R; Jakupi A; Bochenek T; Wladysiuk M; Furtado C; Marković-Peković V; Mardare I; Meshkov D; Fürst J; Tomek D; Cortadellas MO; Zara C; Haycox A; Campbell S; Godman B
Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):251-261. PubMed ID: 30696372
[TBL] [Abstract][Full Text] [Related]
8. Addressing Administrative and Regulatory Burden in Cancer Clinical Trials: Summary of a Stakeholder Survey and Workshop Hosted by the American Society of Clinical Oncology and the Association of American Cancer Institutes.
Vose JM; Levit LA; Hurley P; Lee C; Thompson MA; Stewart T; Hofacker J; Bruinooge SS; Hayes DF
J Clin Oncol; 2016 Nov; 34(31):3796-3802. PubMed ID: 27601549
[No Abstract] [Full Text] [Related]
9. Dream vs. reality: seven case-studies on the desirability and feasibility of cross-border hospital collaboration in Europe.
Glinos IA; Baeten R
Soc Sci Med; 2014 Sep; 117():18-24. PubMed ID: 25025866
[TBL] [Abstract][Full Text] [Related]
10. The European clinical trials regulation (No 536/2014): changes and challenges.
Scavone C; di Mauro G; Pietropaolo M; Alfano R; Berrino L; Rossi F; Tomino C; Capuano A
Expert Rev Clin Pharmacol; 2019 Nov; 12(11):1027-1032. PubMed ID: 31608706
[No Abstract] [Full Text] [Related]
11. The EU Clinical Trials Regulation: key priorities, purposes and aims and the implications for public health.
Flear ML
J Med Ethics; 2016 Mar; 42(3):192-8. PubMed ID: 26831742
[TBL] [Abstract][Full Text] [Related]
12. Global health in the European Union--a review from an agenda-setting perspective.
Aluttis C; Krafft T; Brand H
Glob Health Action; 2014; 7():23610. PubMed ID: 24560264
[TBL] [Abstract][Full Text] [Related]
13. Clinical Trial Application in Europe: What Will Change with the New Regulation?
Giannuzzi V; Altavilla A; Ruggieri L; Ceci A
Sci Eng Ethics; 2016 Apr; 22(2):451-66. PubMed ID: 26037896
[TBL] [Abstract][Full Text] [Related]
14. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
Rose K
Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288
[TBL] [Abstract][Full Text] [Related]
15. The reorganisation of European pharmacovigilance. Part 2. From spontaneous reports to agency reviews and decisions.
Prescrire Int; 2015 Feb; 24(157):50-4. PubMed ID: 25802924
[TBL] [Abstract][Full Text] [Related]
16. [Central and eastern Europe, candidates for the European Union: the emergence of new health care systems. Interview by Marc Duriez with Dr. Marc Danzon . Director of the WHO Regional European office].
Danson M
Sante Publique; 2000 Dec; 12(4):509-12. PubMed ID: 11349336
[No Abstract] [Full Text] [Related]
17. Results from a 1-day workshop on the assessment of quality of life in cancer patients: a joint initiative of the Japan Clinical Oncology Group and the European Organisation for Research and Treatment of Cancer.
Terada M; Nakamura K; Martinelli F; Pe M; Mizusawa J; Eba J; Fukuda H; Kiyota N; Gatellier L; Majima Y; Velikova G; Bottomley A
Jpn J Clin Oncol; 2020 Oct; 50(11):1333-1341. PubMed ID: 32783053
[TBL] [Abstract][Full Text] [Related]
18. Harmful impact of EU clinical trials directive: ...while paediatric oncology is being scuppered.
Mitchell CD
BMJ; 2006 Mar; 332(7542):666. PubMed ID: 16543345
[No Abstract] [Full Text] [Related]
19. Why the EU matters in cancer.
O'Donnell P
Eur J Cancer; 2001 Oct; 37(15):1807. PubMed ID: 11601423
[No Abstract] [Full Text] [Related]
20. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
